Document is current
Any future updates will be listed below
-
Authors
Taddio, Anna
Coldham, Joanne
Logeman, Charlotte
McMurtry, C. Meghan
Little, Cheri
Samborn, Tracy
Bucci, Lucie M.
MacDonald, Noni E.
Shah, Vibhuti
Dribnenki, Cindy
Snider, Joanne
Stephens, Derek
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (FRN 159905)
- License Information
-
More Information
Article History
Received: 23 April 2020
Accepted: 14 January 2021
First Online: 1 February 2021
Ethics approval and consent to participate
: Ethical approval was obtained from the University of Toronto Health Sciences Research Ethics Board (REB) and the REBs for the School Boards of participating schools. Written informed consent was obtained from all focus group participants. Consent was waived by the REB for the remainder of the data to allow collection of population level data. Hence, parent and/or student consent was not required. Principals, however, were able to refuse participation of their school.
: Not applicable.
: AT reports a Section 9 Trademark No. 924835 for CARD™. LB reports that Immunize Canada received grants from Pfizer Inc., Merck Canada, Sanofi Pasteur, Seqiris, and Glaxo-Smith-Kline unrelated to this work. The other authors declare that they have no competing interests.
